Medtech | Ophthalmology Innovation Source

Makower: Making Medtech Bigger, Stronger, Faster

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 054″] Josh Makower, MD, literally wrote (or co-wrote) the book on Medtech Innovation. Makower is a general partner in New Enterprise Associates most recent fund, but he’s worked with the firm as a Venture Partner or EIR since 1995. Makower founded ExploraMed I, II, III, and IV Inc., a series of…

Year 1: What OIS Podcasts Were Most Popular? Part Two

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 051″] We’re thrilled to be celebrating the one-year anniversary of the OIS Podcast. We hope you enjoyed these tales of innovation as much as we have. To celebrate milestone we reveal and review the interviews that most resonated with our listeners. We reviewed numbers Six through Ten in our last episode.…

Year 1: What OIS Podcasts Were Most Popular? Part One

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 050″] We’re thrilled to be celebrating the one-year anniversary of the OIS Podcast. We hope you enjoyed these tales of innovation as much as we have. To celebrate milestone we reveal and review the interviews that most resonated with our listeners. Transcripts Tom Salemi: Hello, everyone, welcome back to the OIS…

Allergan’s Oculeve Acquisition Bolsters Dry Eye, Medtech

The dry eye space has taken a few hits lately with disappointing clinical news on the biopharmaceutical front. But investors and entrepreneurs developing new treatments have to be bolstered by Allergan’s agreeing to purchase early-stage company Oculeve. According to a press release on the deal, Allergan would pay $125 million up front for Oculeve, which…

A Discussion Of Allergan’s Legacy And Future In Medtech Ophthalmology

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 045″] Hear from Allergan’s Past and Future: Highlights of interviews with Brent Saunders and Gavin Herbert. Podcast Guest Brent Saunders Brent Saunders has served as CEO and President of Allergan, formerly Actavis, since July 1, 2014. Previously, Mr. Saunders served as CEO and President of Forest Laboratories from 2013 to 2014.…

Here is How Big Companies Innovate

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 044″] Leaders of Alcon, AMO, Valeant and Zeiss Discuss the Role of Innovation in their Success. Podcast Transcript Tom Salemi: Hi, welcome back to the OIS Podcast. This is Tom Salemi, your host. Thank you so much for joining us today. If you tuned in last week, you heard from J.…

Mynosys

Zepto is an “innovative, disposable device for cataract surgery,” that uses precision-pulse technology to produce an “accurate and reproducible capsulotomy that is quick, safe, and very affordable,” Hendrick said. The Zepto is comprised of silicone, with a soft, clear suction cup—because of the material choice, surgeons have visibility through the cup. It also includes a…

Borrmann Gives View Into Abbott’s Innovation Cycle

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 041″] Leonard Borrmann, Head of R&D at Abbott Medical Optics, explains how the company encourages “failing forward” and other innovative qualities to creating new vision devices. Podcast Guest Leonard Borrmann Leonard joined Abbott as Divisional Vice President R&D, in February 2009, with the acquisition of Advanced Medical Optics. During his five…

Avedro CEO Muller Answers Questions About The FDA’s Questions

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 039″] David Muller, CEO of Avedro, addresses delays in the FDA’s review of the company’s riboflavin ophthalmic solution/KXL System for corneal cross-linking and discusses the considerable potential of PIXL. Podcast Guest David Muller, PhD Dr. Muller recognized the potential of using advanced methods to gently reshape the cornea and in 2007…

Lindstrom Wins Ophthalmology Innovator Award

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 038″] OIS Co-Chair Bill Link interviews Richard Lindstrom, MD, after awarding him with the Ophthalmology Innovator Award at OIS@ASCRS on April 16, in San Diego. Podcast Guests William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American…

Co-Chair Link Gives Overview Of Upcoming OIS

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 033″] With just two weeks away from OIS@ASCRS, Conference Co-Chair Bill Link, managing director of Versant Ventures, reviews the highlights of the upcoming meeting including a tight focus on glaucoma and plenary talk by J. Michael Pearson of Valeant. Podcast Guests William J. Link, PhD Bill was Founder, Chairman and CEO…

Alcon’s Attias Offers Insights On Innovation

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 032″]